Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial

Figure 2

C-index plot for clinicopathological parameters and EndoPredict test results between breast cancer patients with ER+/HER2− tumors. C-index estimates for different groupings of prognostic parameters are shown: ER + PR + Ki67, ER + PR + Ki67 + tumor size, ER + PR + Ki67 + tumor size + nodal status, all clinicopathological parameters (nodal status, tumor size, grade, treatment arm, and ER and PR status and Ki67 index), all clinicopathological parameters + EndoPredict (EP) score, and combined molecular and clinical EPclin. ER: Estrogen receptor; PR: Progesterone receptor. P-values indicate whether additional molecular parameters add significant prognostic information to clinical variables.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us